Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

FDA approves new AI-enabled wearable cardioverter defibrillator
The newly approved device can be worn for up to a week at a time, with no daily maintenance required, and includes advanced AI algorithms that minimize the risk of false alarms or inappropriate shocks.
Cardiologists share late-breaking TAVR data on first day of SCAI 2025
New TAVR data on SAPT vs. DAPT and prosthesis-patient mismatch among women were some of the many highlights of the conference's opening day.
Latest EARLY TAVR data suggest it is time to update industry guidelines
Philippe Genereux, MD, principal investigator of EARLY TAVR, presented new data at ACC.25 showing intervening early on crossover patients with asymptomatic severe aortic stenosis led to better outcomes and a reduced stroke rate.
A victory for early treatment: FDA approves first TAVR valves for asymptomatic severe aortic stenosis
The FDA has approved the balloon-expandable Sapien 3 TAVR platform from Edwards Lifesciences for treating asymptomatic severe aortic stenosis. This is the first time the agency has approved any TAVR technology to be used in asymptomatic patients.
Focal ablation yields lower treatment failure rates than surgery for prostate cancer
This is the first randomized controlled trial to compare the use of ultrasound energy-based focal ablation to robot-assisted radical prostatectomy.

Estrogen may be linked to heart rhythm issues

A new experimental study focused on how different sex hormones can affect the heart's ability to properly pump blood. Estradiol, the most active form of estrogen, stood out as a hormone that requires additional research.

Medtronic gains key approval for new mapping and ablation system

Medtronic acquired the technology in a 2022 deal reportedly worth $925 million.

Projected supply and demand of radiation oncology: Can the workforce keep up?

In years past, concerns have been raised over whether a growing radiation oncology workforce would eventually outpace patient demands, but a new report brings positive news.

New imaging tool could change how decisions are made in the labor and delivery room

Electromyometrial imaging creates 3D maps of contractions during labor in real-time, which can help clinicians track contraction patterns and make decisions regarding patient management.

Steven Nissen, MD, chief academic officer of the Heart, Vascular and Thoracic Institute, Cleveland Clinic, explains the details from the late-breaking CLEAR Outcomes trial presented at the 2023 American College of Cardiology (ACC) meeting found bempedoic acid can be used in statin-intolerant patients to reduce low-density lipoprotein (LDL) cholesterol levels. #ACC #ACC23 Nexletol

CLEAR Outcomes trial shows statin-intolerant patients benefit from bempedoic acid

Steven Nissen, MD, spoke with Cardiovascular Business at ACC.23 about the late-breaking CLEAR Outcomes trial.

Mediterranean diet reduces risk of CVD, death among women

The popular diet appears to benefit women even more than it benefits men.

The SAPIEN 3 Ultra (S3U) transcatheter heart valve from Edwards Lifesciences is

Next-generation TAVR valve delivers strong outcomes, reduced PVL after one year

A team of specialists examined new outcomes data related to the SAPIEN 3 Ultra transcatheter heart valve, sharing its findings in EuroIntervention.

cardiologist patient heart compensation starting salary 2022 interventional cardiologist

Pulsed-field ablation for AFib not linked to any signs of bronchial damage

As this new ablation technique continues to gain momentum, researchers are hoping to learn as much as possible about any potential side effects.

Clinical

FDA approves new AI-enabled wearable cardioverter defibrillator

Cardiologists share late-breaking TAVR data on first day of SCAI 2025

Latest EARLY TAVR data suggest it is time to update industry guidelines

A victory for early treatment: FDA approves first TAVR valves for asymptomatic severe aortic stenosis

Focal ablation yields lower treatment failure rates than surgery for prostate cancer